Cell Therapy and Cell Engineering Facility
Overview

Agnès Viale
Interim Co-Director

Kevin J. Curran
Interim Co-Director

Xiuyan Wang
Associate Director
The Cell Therapy and Cell Engineering Facility develops, validates, and implements procedures critical to gene transfer-related clinical research at Memorial Sloan Kettering. The quality assurance and quality control unit (QA/QC) is essential for providing a laboratory environment compliant with NIH and FDA guidelines.
Featured News

Testing CRISPR-Edited CAR T Cell Therapy in Lymphoma Clinical Trial
A groundbreaking clinical trial is testing CAR T cells created using CRISPR gene-editing technology.
Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
People

Agnès Viale, PhD
Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

Kevin J. Curran, MD
Assistant Attending, Pediatric Bone Marrow Transplant Service
Members

Jagruti Chaudhari

Tasmin Farzana

Maria Freeman

Paridhi Gautam

Amy Guzman
Laboratory Quality Assurance Coordinator

Melanie Hall

Lissa Rojas

Keyur Thummar

Nicholas Yeomans

Juan Zhen

Research Assistant

Research Assistant

Quality Control Assistant

Client Tech Specialist

Senior Research Assistant
Quality Assurance Specialist

Senior Research Specialist





Laboratory Quality Assurance Coordinator





Alumni

Research Assistant

Research Assistant

Senior Research Technician

Quality Assurance Manager
Research Assistant

Secretary

Senior Research QC Lab Technician
Get in Touch
-
Director Email
-
Director Email
-
Director Email